Page last updated: 2024-08-24

tenofovir and Depression

tenofovir has been researched along with Depression in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (60.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Cantor, R; Clark, D; DiFlavis, L; Koenig, HC; Lalley-Chareczko, L; Nahan, RA; Ramos, MT; Troutman, GS; Young, LB1
Adam, A; Buhk, T; Fenske, S; Hansen, S; Hoffmann, C; Sabranski, M; Schewe, K; Stellbrink, HJ1
Amico, KR; Avelino-Silva, VI; Burns, D; Chodacki, P; Defechereux, PA; Fernandez, T; Glidden, DV; Grant, RM; Liu, AY; Mayer, KH; McMahan, VM; Mehrotra, M; Vargas, L1
Caroleo, B; Gallelli, L; Perticone, F; Staltari, O1
Ananworanich, J; Bhakeecheep, S; Bowonwattanuwong, C; Bunupuradah, T; Chetchotisakd, P; Hirschel, B; Jirajariyavej, S; Klinbuayaem, V; Mahanontharit, A; Munsakul, W; Prasithsirikul, W; Ruxrungtham, K; Sophonphan, J; Valcour, V1

Trials

2 trial(s) available for tenofovir and Depression

ArticleYear
Depression and Oral FTC/TDF Pre-exposure Prophylaxis (PrEP) Among Men and Transgender Women Who Have Sex With Men (MSM/TGW).
    AIDS and behavior, 2016, Volume: 20, Issue:7

    Topics: Adolescent; Adult; Anti-HIV Agents; Cross-Sectional Studies; Depression; Emtricitabine; Female; HIV Infections; Homosexuality, Male; Humans; Longitudinal Studies; Male; Middle Aged; Pre-Exposure Prophylaxis; Sexual Behavior; Tenofovir; Transgender Persons

2016
Neurocognitive impairment in patients randomized to second-line lopinavir/ritonavir-based antiretroviral therapy vs. lopinavir/ritonavir monotherapy.
    Journal of neurovirology, 2012, Volume: 18, Issue:6

    Topics: Adenine; Adult; CD4 Lymphocyte Count; Cognition Disorders; Depression; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Lopinavir; Male; Organophosphonates; Reverse Transcriptase Inhibitors; Ritonavir; RNA, Viral; Tenofovir; Viral Load

2012

Other Studies

3 other study(ies) available for tenofovir and Depression

ArticleYear
Correlation of pre-exposure prophylaxis adherence to a mental health diagnosis or experience of childhood trauma in high-risk youth.
    International journal of STD & AIDS, 2020, Volume: 31, Issue:5

    Topics: Adolescent; Adult; Adult Survivors of Child Adverse Events; Anti-HIV Agents; Anxiety; Cross-Sectional Studies; Depression; Female; HIV Infections; Humans; Male; Medication Adherence; Patient Health Questionnaire; Pre-Exposure Prophylaxis; Prevalence; Tenofovir

2020
Short-term neuropsychiatric tolerability of bictegravir combined with emtricitabine/tenofovir alafenamide in clinical practice.
    Antiviral therapy, 2020, Volume: 25, Issue:2

    Topics: Adenine; Adult; Aged; Aged, 80 and over; Amides; Anti-HIV Agents; Depression; Emtricitabine; Female; Heterocyclic Compounds, 3-Ring; HIV Infections; HIV-1; Humans; Male; Middle Aged; Piperazines; Pyridones; Retrospective Studies; Tenofovir; Time Factors; Young Adult

2020
Reactivation of chronic hepatitis B during treatment with tenofovir disoproxil fumarate: drug interactions or low adherence?
    BMJ case reports, 2015, Jun-29, Volume: 2015

    Topics: Alanine Transaminase; Antiviral Agents; Central Nervous System Agents; Depression; Drug Interactions; Drug Resistance, Viral; Drug Therapy, Combination; Fumarates; Hepatitis B virus; Hepatitis B, Chronic; Humans; Male; Medication Adherence; Middle Aged; Tenofovir; Transaminases; Viral Load; Virus Activation

2015